HomeRVVTF • OTCMKTS
add
Revive Therapeutics Ltd
Previous close
$0.022
Day range
$0.021 - $0.023
Year range
$0.0050 - $0.025
Market cap
12.56M CAD
Avg Volume
222.77K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 481.43K | -74.07% |
Net income | -577.18K | 69.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -481.36K | 74.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 46.42K | -95.58% |
Total assets | 9.63M | -26.75% |
Total liabilities | 3.69M | 10.84% |
Total equity | 5.94M | — |
Shares outstanding | 418.56M | — |
Price to book | 2.19 | — |
Return on assets | -12.44% | — |
Return on capital | -19.51% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -577.18K | 69.17% |
Cash from operations | -73.99K | 95.48% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 65.00K | -96.78% |
Net change in cash | -8.99K | -102.64% |
Free cash flow | 204.52K | 122.35% |
About
Founded
2012
Headquarters
Website